|
AHCTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.32579999995764E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29249999591963E-08 |
| Normal-vs-Stage2 |
5.158400E-03 |
| Normal-vs-Stage3 |
8.446200E-01 |
| Normal-vs-Stage4 |
9.169200E-01 |
| Stage1-vs-Stage2 |
8.500200E-01 |
| Stage1-vs-Stage3 |
2.398300E-03 |
| Stage1-vs-Stage4 |
1.961200E-01 |
| Stage2-vs-Stage3 |
5.873900E-02 |
| Stage2-vs-Stage4 |
2.388800E-01 |
| Stage3-vs-Stage4 |
8.310600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.5146000000319E-06 |
| Normal-vs-AfricanAmerican |
1.380710E-04 |
| Normal-vs-Asian |
1.398040E-02 |
| Caucasian-vs-AfricanAmerican |
7.728000E-01 |
| Caucasian-vs-Asian |
9.322800E-01 |
| AfricanAmerican-vs-Asian |
9.872600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54930002160825E-09 |
| Normal-vs-Female |
5.881400E-01 |
| Male-vs-Female |
4.172900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.759700E-02 |
| Normal-vs-Extreme_Weight |
1.78319999877274E-08 |
| Normal-vs-Obese |
3.046300E-02 |
| Normal-vs-Extreme_Obese |
8.37150000000397E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.049850E-01 |
| Normal_Weight-vs-Obese |
7.727000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.205200E-01 |
| Extreme_Weight-vs-Obese |
1.109560E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.279200E-01 |
| Obese-vs-Extreme_Obese |
2.351200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.195000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.244410E-02 |
| Normal-vs-Age(61-80Yrs) |
4.43819980766591E-10 |
| Normal-vs-Age(81-100Yrs) |
2.829700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.730000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.974270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.220000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.630600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.972320E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.737600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.55659995793434E-09 |
| Normal-VS-Type2 PRCC |
1.458310E-03 |
| Normal-VS-KIRP CIMP |
1.444990E-01 |
| Normal-VS-Unclassified PRCC |
1.672500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.918200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.376050E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.419000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.781800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.687000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.104500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.03830000047967E-08 |
| Normal-vs-N1 |
1.314800E-01 |
| Normal-vs-N2 |
8.658400E-01 |
| N0-vs-N1 |
8.381200E-04 |
| N0-vs-N2 |
8.474400E-02 |
| N1-vs-N2 |
4.731000E-01 |
|
|
